Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Chronic pain
Nano-ECS modulator Adezunap improves therapy success
- Psoriasis and PsA
Biologics, oral peptide and trivalent nanobody – current results and trends
- Cancer in Europe: facts and analysis
New Health Policy Report published
- Gastrointestinal complaints
PPI regulation under the microscope
- Wound management: clinical diagnostics
Assessing the risk of infection – from the ABCDE to the TILI score
- Study report
Digital patient education for atrial fibrillation shows measurable effects
- New practice guideline for fibromyalgia syndrome
Good times, bad times
- Important basics and studies on cancer and the psyche